US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.690
  • -0.050-2.87%
Close Mar 25 16:00 ET
  • 1.699
  • +0.009+0.56%
Post 16:13 ET
60.65MMarket Cap-0.83P/E (TTM)

Immuneering Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.69%64.07M
13.84%18.56M
9.68%15.27M
10.43%14.91M
4.98%15.33M
12.54%58.41M
16.56%16.3M
5.45%13.93M
15.50%13.51M
12.14%14.6M
Selling and administrative expenses
-4.07%16.08M
-15.76%3.69M
3.75%4.01M
5.17%4.25M
-6.05%4.12M
7.39%16.76M
6.77%4.39M
0.86%3.87M
9.21%4.05M
10.86%4.38M
-General and administrative expense
-4.07%16.08M
-15.76%3.69M
3.75%4.01M
5.17%4.25M
-6.05%4.12M
7.39%16.76M
6.77%4.39M
0.86%3.87M
9.21%4.05M
10.86%4.38M
Research and development costs
15.23%47.96M
24.74%14.86M
11.97%11.25M
12.69%10.65M
9.71%11.2M
14.77%41.62M
20.65%11.91M
7.33%10.05M
18.44%9.45M
12.72%10.21M
Depreciation amortization depletion
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
-2.62%29.27K
0.01%7.32K
0.00%7.32K
0.00%7.32K
-9.70%7.32K
-Depreciation and amortization
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
-2.62%29.27K
0.01%7.32K
0.00%7.32K
0.00%7.32K
-9.70%7.32K
Operating profit
-9.69%-64.07M
-13.84%-18.56M
-9.68%-15.27M
-10.43%-14.91M
-4.98%-15.33M
-12.89%-58.41M
-16.57%-16.3M
-5.60%-13.93M
-15.96%-13.51M
-12.95%-14.6M
Net non-operating interest income expense
-28.10%2.59M
-44.94%415.24K
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
255.56%3.61M
46.10%754.14K
283.67%855.53K
716.57%1.17M
527.35%831.27K
Non-operating interest income
-28.10%2.59M
-44.94%415.24K
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
255.56%3.61M
46.10%754.14K
283.67%855.53K
716.57%1.17M
527.35%831.27K
Other net income (expense)
-66.91%441.49K
-80.31%91.43K
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
515.31%1.33M
107.97%464.35K
293.59%475.6K
724.43%150.19K
336.52%244.13K
Other non- operating income (expenses)
-66.91%441.49K
-80.31%91.43K
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
515.31%1.33M
107.97%464.35K
293.59%475.6K
724.43%150.19K
336.52%244.13K
Income before tax
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-13.87%-15.08M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
Income tax
Net income
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-13.87%-15.08M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
Net income continuous Operations
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-13.87%-15.08M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
Minority interest income
Net income attributable to the parent company
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
Basic earnings per share
-8.51%-2.04
-11.54%-0.58
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
1.57%-1.88
-4.00%-0.52
12.24%-0.43
2.27%-0.43
-4.08%-0.51
Diluted earnings per share
-8.51%-2.04
-11.54%-0.58
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
1.57%-1.88
-4.00%-0.52
12.24%-0.43
2.27%-0.43
-4.08%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.69%64.07M13.84%18.56M9.68%15.27M10.43%14.91M4.98%15.33M12.54%58.41M16.56%16.3M5.45%13.93M15.50%13.51M12.14%14.6M
Selling and administrative expenses -4.07%16.08M-15.76%3.69M3.75%4.01M5.17%4.25M-6.05%4.12M7.39%16.76M6.77%4.39M0.86%3.87M9.21%4.05M10.86%4.38M
-General and administrative expense -4.07%16.08M-15.76%3.69M3.75%4.01M5.17%4.25M-6.05%4.12M7.39%16.76M6.77%4.39M0.86%3.87M9.21%4.05M10.86%4.38M
Research and development costs 15.23%47.96M24.74%14.86M11.97%11.25M12.69%10.65M9.71%11.2M14.77%41.62M20.65%11.91M7.33%10.05M18.44%9.45M12.72%10.21M
Depreciation amortization depletion 0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K-2.62%29.27K0.01%7.32K0.00%7.32K0.00%7.32K-9.70%7.32K
-Depreciation and amortization 0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K-2.62%29.27K0.01%7.32K0.00%7.32K0.00%7.32K-9.70%7.32K
Operating profit -9.69%-64.07M-13.84%-18.56M-9.68%-15.27M-10.43%-14.91M-4.98%-15.33M-12.89%-58.41M-16.57%-16.3M-5.60%-13.93M-15.96%-13.51M-12.95%-14.6M
Net non-operating interest income expense -28.10%2.59M-44.94%415.24K-36.05%547.07K-29.15%826.1K-3.17%804.88K255.56%3.61M46.10%754.14K283.67%855.53K716.57%1.17M527.35%831.27K
Non-operating interest income -28.10%2.59M-44.94%415.24K-36.05%547.07K-29.15%826.1K-3.17%804.88K255.56%3.61M46.10%754.14K283.67%855.53K716.57%1.17M527.35%831.27K
Other net income (expense) -66.91%441.49K-80.31%91.43K-72.81%129.31K-94.86%7.72K-12.74%213.04K515.31%1.33M107.97%464.35K293.59%475.6K724.43%150.19K336.52%244.13K
Other non- operating income (expenses) -66.91%441.49K-80.31%91.43K-72.81%129.31K-94.86%7.72K-12.74%213.04K515.31%1.33M107.97%464.35K293.59%475.6K724.43%150.19K336.52%244.13K
Income before tax -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-13.87%-15.08M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M
Income tax
Net income -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-13.87%-15.08M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M
Net income continuous Operations -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-13.87%-15.08M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M
Minority interest income
Net income attributable to the parent company -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M
Basic earnings per share -8.51%-2.04-11.54%-0.58-13.95%-0.49-9.30%-0.473.92%-0.491.57%-1.88-4.00%-0.5212.24%-0.432.27%-0.43-4.08%-0.51
Diluted earnings per share -8.51%-2.04-11.54%-0.58-13.95%-0.49-9.30%-0.473.92%-0.491.57%-1.88-4.00%-0.5212.24%-0.432.27%-0.43-4.08%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.